Compare Elastic NV (ESTC) vs Hims and Hers Health Inc (HIMS) Price & Performance

Elastic (ESTC) trades at $98.23, up 5.51% today, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent product launches, including AI-driven metrics and serverless vector database offerings, highlight innovation in observability and search. Revenue growth is projected to increase from $1.48B in 2025 to $1.8B in 2026, with net income turning positive to $376M.

The outlook is positive given earnings momentum and strategic product expansions, though high valuation ratios and insider selling pose risks. The consensus price target of $79.50 suggests potential downside from current levels, but bullish technicals and institutional interest support a constructive view. Key risks include competitive pressures and execution challenges in scaling new AI integrations.

Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.

The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.